Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Therapeutic Potential of Metformin in Neurodegenerative Diseases
Carola Rotermund, Gerrit Machetanz, Julia C. Fitzgerald
Frontiers in Endocrinology (2018) Vol. 9
Open Access | Times Cited: 255

Showing 1-25 of 255 citing articles:

Ageing as a risk factor for neurodegenerative disease
Yujun Hou, Xiuli Dan, Mansi Babbar, et al.
Nature Reviews Neurology (2019) Vol. 15, Iss. 10, pp. 565-581
Closed Access | Times Cited: 2410
Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing
Stephen C. Cunnane, Eugenia Trushina, Cecilie Morland, et al.
Nature Reviews Drug Discovery (2020) Vol. 19, Iss. 9, pp. 609-633
Open Access | Times Cited: 686
Benefits of Metformin in Attenuating the Hallmarks of Aging
Ameya Kulkarni, Sriram Gubbi, Nir Barzilai
Cell Metabolism (2020) Vol. 32, Iss. 1, pp. 15-30
Open Access | Times Cited: 553
Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus
Marc Foretz, Bruno Guigas, Benoı̂t Viollet
Nature Reviews Endocrinology (2019) Vol. 15, Iss. 10, pp. 569-589
Closed Access | Times Cited: 529
Impaired dopamine metabolism in Parkinson’s disease pathogenesis
Anna Masato, Nicoletta Plotegher, Daniela Boassa, et al.
Molecular Neurodegeneration (2019) Vol. 14, Iss. 1
Open Access | Times Cited: 270
Metformin-Induced Mitochondrial Complex I Inhibition: Facts, Uncertainties, and Consequences
Éric Fontaine
Frontiers in Endocrinology (2018) Vol. 9
Open Access | Times Cited: 212
Metformin limits osteoarthritis development and progression through activation of AMPK signalling
Jun Li, Bin Zhang, Wei‐Xiao Liu, et al.
Annals of the Rheumatic Diseases (2020) Vol. 79, Iss. 5, pp. 635-645
Open Access | Times Cited: 212
Metformin: Is it a drug for all reasons and diseases?
Chris R. Triggle, Ibrahim Mohammed, Khalifa Bshesh, et al.
Metabolism (2022) Vol. 133, pp. 155223-155223
Open Access | Times Cited: 186
Astrocytes as Key Regulators of Brain Energy Metabolism: New Therapeutic Perspectives
Elidie Béard, Sylvain Lengacher, Sara Dias, et al.
Frontiers in Physiology (2022) Vol. 12
Open Access | Times Cited: 174
Skin senescence: mechanisms and impact on whole-body aging
Ana Catarina Franco, Célia A. Aveleira, Cláudia Cavadas
Trends in Molecular Medicine (2022) Vol. 28, Iss. 2, pp. 97-109
Open Access | Times Cited: 173
Targeting autophagy in disease: established and new strategies
Muhammed Koçak, Saba Ezazi Erdi, Guillem Jorba, et al.
Autophagy (2021) Vol. 18, Iss. 3, pp. 473-495
Open Access | Times Cited: 149
Mechanisms of action of metformin in type 2 diabetes: Effects on mitochondria and leukocyte-endothelium interactions
Nadezda Apostolova, Francesca Iannantuoni, Aleksandra Gruevska, et al.
Redox Biology (2020) Vol. 34, pp. 101517-101517
Open Access | Times Cited: 140
Finding genetically-supported drug targets for Parkinson’s disease using Mendelian randomization of the druggable genome
Catherine S. Storm, Demis A. Kia, Mona Mohammad Almramhi, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 129
Mitochondria as an important target of metformin: The mechanism of action, toxic and side effects, and new therapeutic applications
Jin Feng, Xiaohui Wang, Xiaochun Ye, et al.
Pharmacological Research (2022) Vol. 177, pp. 106114-106114
Closed Access | Times Cited: 109
Pharmacotherapy of type 2 diabetes: An update and future directions
Antea DeMarsilis, Niyoti Reddy, Chrysoula Boutari, et al.
Metabolism (2022) Vol. 137, pp. 155332-155332
Closed Access | Times Cited: 98
Antidiabetic agents as a novel treatment for Alzheimer’s and Parkinson’s disease
Joseph Nowell, Eleanor G Blunt, Dhruv Gupta, et al.
Ageing Research Reviews (2023) Vol. 89, pp. 101979-101979
Open Access | Times Cited: 84
Mitochondria and Brain Disease: A Comprehensive Review of Pathological Mechanisms and Therapeutic Opportunities
Vicente Javier Clemente‐Suárez, Laura Redondo-Flórez, Ana Isabel Beltrán-Velasco, et al.
Biomedicines (2023) Vol. 11, Iss. 9, pp. 2488-2488
Open Access | Times Cited: 72
Associations Between Diabetes Mellitus and Neurodegenerative Diseases
Leszek Szablewski
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 542-542
Open Access | Times Cited: 3
Doxorubicin and cisplatin induced cognitive impairment: The possible mechanisms and interventions
Benjamin Ongnok, Nipon Chattipakorn, Siriporn C. Chattipakorn
Experimental Neurology (2019) Vol. 324, pp. 113118-113118
Closed Access | Times Cited: 104
Metformin treatment in late middle age improves cognitive function with alleviation of microglial activation and enhancement of autophagy in the hippocampus
Maheedhar Kodali, Sahithi Attaluri, Leelavathi N. Madhu, et al.
Aging Cell (2021) Vol. 20, Iss. 2
Open Access | Times Cited: 102
Role of Thioredoxin-Interacting Protein in Diseases and Its Therapeutic Outlook
Naila Qayyum, Muhammad Haseeb, Moon Suk Kim, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 5, pp. 2754-2754
Open Access | Times Cited: 102
Emerging neuroprotective effect of metformin in Parkinson’s disease: A molecular crosstalk
Yam Nath Paudel, Efthalia Angelopoulou, Christina Piperi, et al.
Pharmacological Research (2019) Vol. 152, pp. 104593-104593
Closed Access | Times Cited: 90
Metformin use is associated with a reduced risk of mortality in patients with diabetes hospitalised for COVID-19
Jean‐Daniel Lalau, Abdallah Al‐Salameh, Samy Hadjadj, et al.
Diabetes & Metabolism (2020) Vol. 47, Iss. 5, pp. 101216-101216
Open Access | Times Cited: 89
Early Biomarkers of Neurodegenerative and Neurovascular Disorders in Diabetes
Aleksandra Gąsecka, Dominika Siwik, Magdalena Gajewska, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 9, pp. 2807-2807
Open Access | Times Cited: 88
Metformin attenuates plaque-associated tau pathology and reduces amyloid-β burden in APP/PS1 mice
Yanxing Chen, Shuai Zhao, Ziqi Fan, et al.
Alzheimer s Research & Therapy (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 86
Page 1 - Next Page

Scroll to top